K221225 is an FDA 510(k) clearance for the Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer. This device is classified as a Radioimmunoassay, Thyroid-stimulating Hormone (Class II - Special Controls, product code JLW).
Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on November 10, 2022, 196 days after receiving the submission on April 28, 2022.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1690.
| 510(k) Number | K221225 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | April 28, 2022 |
| Decision Date | November 10, 2022 |
| Days to Decision | 196 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JLW — Radioimmunoassay, Thyroid-stimulating Hormone |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.1690 |